Live feed
Filing
SC 13G
SC 13G0001274173-24-000003·Compass Therapeutics, Inc.
Schedule 13G ownership disclosure
Compass Therapeutics Inc
Security class unavailable · CUSIP: 20454B104
Event date: 2024-01-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,647,740
- Percent of class
- 6.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-24-000003
- Form type
- SC 13G
- Filer
- Compass Therapeutics, Inc.
- CIK
- CIK 1738021
- Filed
- Feb 01, 2024
- Reporting period
- Jan 22, 2024
- Description
- Schedule 13G beneficial ownership